MedTrace Logo

Prevention of Osteoporosis in Breast Cancer Survivors

NCT00567606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 249

Last updated 2023-11-30

No results posted yet for this study

Summary

The purpose of this study is to test whether strength/weight training exercises enhance the effectiveness of calcium, vitamin D, and risedronate for the prevention and treatment of osteoporosis in postmenopausal breast cancer survivors.

Conditions

  • Postmenopausal Osteoporosis

Interventions

OTHER

Strength/Weight Training & Drug/Supplement

G1 group receives 1200 mg of calcium and 400 IU of vitamin D supplements per day, 35 mg of risedronate per week and strength/weight training exercises for upper and lower extremities and the spine.

COMBINATION_PRODUCT

Drug/Supplement only

G2 group receives 1200 mg of calcium and 400 IU of vitamin D supplements per day, 35 mg of risedronate per week, but do not participate in strength/weight training exercises.

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • University of Nebraska

    lead OTHER

Principal Investigators

  • Nancy L Waltman, PhD, ARNP · University of Nebraska Medical Center, College of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-04-01
Primary Completion
2007-12-01
Completion
2007-12-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00567606 on ClinicalTrials.gov